Lactobacillus Gasseri for Weight Loss Support

L. gasseri produced small visceral fat reductions in East Asian trials, but the effect was modest, reversed after stopping and has not replicated widely.

Overview

L. gasseri produced small visceral fat reductions in East Asian trials, but the effect was modest, reversed after stopping and has not replicated widely.

Verdict

Mixed evidence

A marginal nudge at best. Real, measurable, and far smaller than any dietary change worth making.

How It Works

L. gasseri reduces dietary fat absorption and increases faecal fat excretion, alters bile-salt hydrolase activity, and lowers low-grade inflammatory signalling in adipose tissue.

Dosing & Protocol

Typical dose

Recommended dose: 10 billion CFU/day
Expected timeframe: 12 weeks

Protocol

0: [object Object]
1: [object Object]
2: [object Object]
3: [object Object]

Evidence

What the studies say

The headline result is a 12-week randomized trial of strain SBT2055 in 210 Japanese adults with elevated visceral fat: roughly an 8% reduction in visceral fat area versus control, with about 1 kg of body weight and 1-2 cm of waist circumference. A follow-up phase found the benefit disappeared within four weeks of discontinuation. Korean trials of BNR17 report the same direction and magnitude. Independent replication outside East Asian cohorts is scarce, and several probiotic weight-loss meta-analyses find pooled effects that are statistically detectable but clinically trivial. Honest negative: nothing here supports probiotics as a weight-loss strategy on their own - the trials paired supplementation with stable diets and still landed around 1 kg.

Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial

Score: 7/10

2010

rct

n=87

Kadooka Y, Sato M, Imaizumi K +6 more

Visceral and subcutaneous fat areas decreased significantly with LG2055 compared with control, alongside reductions in body weight and waist circumference.

View source

Effects of Lactobacillus gasseri BNR17 on overweight and obese adults: a randomized, double-blind clinical trial

Score: 7/10

2018

rct

n=90

Kim J, Yun JM, Kim MK +2 more

Body weight and BMI did not differ significantly from placebo; only waist and hip circumference showed small reductions in the high-dose group.

View source

Safety

Caveats

Benefits reverse within about four weeks of stopping. Effect sizes are small enough to be lost in normal weight fluctuation.

Less likely to help if

People not controlling diet saw no benefit; non-East-Asian cohorts remain largely untested.

Medical Disclaimer

The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.